A Novel Intersection: Cytomegalovirus Gastritis Following Cemiplimab and Talimogene Laherparepvec in a Patient With Advanced Cutaneous Squamous Cell Carcinoma

ABSTRACT Cytomegalovirus (CMV) reactivation is a rare complication in patients treated with immune checkpoint inhibitors (ICIs), typically occurring after immunosuppressive therapy for immune‐related adverse events (irAEs). Here, we report a unique case of severe CMV gastritis in a patient receiving...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Goar Egoryan, Alex Zimmet, Mingwei Yu, Joseph Pozdol, Aruna Subramanian, Sunil Reddy, Joanna Nelson
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Wiley 2024-12-01
Σειρά:	Clinical Case Reports
Θέματα:	cemiplimab cytomegalovirus immunotherapy talimogene laherparepvec
Διαθέσιμο Online:	https://doi.org/10.1002/ccr3.9632
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!